Skip to main content
. 2024 Jul 29;144(18):1951–1961. doi: 10.1182/blood.2024024761

Table 2.

Multivariable analyses in the 1762 patients with complete data for the 6 prognostic covariates in the training data set

Covariates Regression coefficient HR (95% CI) P value
Multivariable Cox analyses
 Male 0.2026 1.2 (1.0-1.5) .02
 Age/100, y 1.5668 4.8 (2.3-9.8) <.001
 (Hemoglobin/100)−2, g/L 0.3108 1.4 (1.3-1.5) <.001
 Blood blasts, % 0.1085 1.1 (1.1-1.2) <.001
 Spleen size, cm below costal margin 0.0675 1.1 (1.0-1.1) <.001
 High-risk ACAs in Ph+ cells 0.5458 1.7 (1.1-2.8) .03
Multivariable Fine-Gray analyses
 Male 0.1919 1.2 (1.0-1.5) .01
 Age/100, y 1.6160 5.0 (2.5-10.3) <.001
 (Hemoglobin/100)−2, g/L 0.3105 1.4 (1.2-1.5) <.001
 Blood blasts, % 0.1087 1.1 (1.1-1.2) <.001
 Spleen size, cm below costal margin 0.0671 1.1 (1.0-1.1) <.001
 High-risk ACAs in Ph+ cells 0.5461 1.7 (1.1-2.8) .02

HR, hazard ratio; N, no; Y, yes.

High-risk ACAs in Ph+ cells were scored as categorical covariates (“Y/N”) in the regression models.